Search Within

Zachary Drew Epstein-Peterson

Formats
  1. Meeting Abstract (56)
  2. Journal Article (22)
  3. Review (9)
  4. Research Letter (7)
  5. Editorial (1)
Groups
  1. Hematologic Malignancies, Division of (95)
  2. Hematology-Oncology Fellows (95)
  3. Weinberg Fellows (95)
  4. Department of Medicine (91)
  5. Center for Hematologic Malignancies (90)
  6. Lymphoma (70)

More Groups

People
  1. Steven Horwitz (47)
  2. Alison Moskowitz (45)
  3. Anita Kumar (44)
  4. Gilles Salles (38)
  5. Maria Palomba (38)
  6. Andrew Zelenetz (35)

More People

Years
  1. 2025 (9)
  2. 2024 (23)
  3. 2023 (24)
  4. 2022 (10)
  5. 2021 (8)
  6. 2020 (7)

More Years

Publications
  1. Blood (49)
  2. Blood Advances (5)
  3. Haematologica (5)
  4. Hematological Oncology (4)
  5. Leukemia Research (4)
  6. American Journal of Hematology (3)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. Wiley Blackwell (6)
  3. Ferrata Storti Foundation (5)
  4. Elsevier Ltd (4)
  5. Nature Publishing Group (4)
  6. John Wiley & Sons, Inc. (3)

More Publishers

Results (95)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation between TP53 mutational status and digital quantification of p53 immunohistochemistry in mantle cell lymphoma
    Journal Article

    Yan, M.; Sethi, S.; Epstein-Peterson, Z.; Kumar, A.; Dogan, A.; Galera, P.
    Virchows Archiv (2025)

    Fulltext@MSK | Save
  • Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: Insights from a retrospective analysis
    Journal Article

    Luttwak, E.; Robin, E. T.; Drill, E.; Boardman, A.; Caron, P.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Predictors of outcomes with covalent BTK inhibitor treatment in relapsed/refractory TP53-mutant mantle cell lymphoma
    Research Letter

    Uppal, M.; Joseph, A.; Drill, E.; Hamlin, P.; Falchi, L.; Noy, A.; Owens, C.; Epstein-Peterson, Z. D.; Salles, G.; Zelenetz, A. D.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma
    Journal Article

    Raj, S. S.; Fei, T.; Fried, S.; Ip, A.; Fein, J. A.; Leslie, L. A.; Alarcon Tomas, A.; Leithner, D.; Peled, J. U.; Corona, M.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
    Journal Article

    Fiore, D.; Cappelli, L. V.; Zhaoqi, L.; Kotlov, N.; Sorokina, M.; Phillip, J.; Zumbo, P.; Yoffe, L.; Ghione, P.; Wang, A.; more...
    Cell Reports Medicine (2025)

    Fulltext@MSK | Save
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes
    Research Letter

    Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Horwitz, S. M.; Johnson, W.; Moskowitz, A. J.; Myskowski, P.; Pulitzer, M.; Geller, S.
    Journal of the European Academy of Dermatology and Venereology (2025)

    Fulltext@MSK | Save
  • Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: Real-life experience
    Journal Article

    Cassanello, G.; Drill, E.; Rivas-Delgado, A.; Okwali, M.; Isgor, I.; Caron, P. C.; Epstein-Peterson, Z.; Ghione, P.; Hamlin, P. A.; Lue, J. K.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • New treatments for adult T-cell leukemia/lymphoma
    Review

    Epstein-Peterson, Z. D.; Gurumurthi, A.; Horwitz, S. M.
    Leukemia Research (2025)

    Fulltext@MSK | Save
  • Rituximab plus /- ibrutinib as first line therapy for marginal zone lymphoma
    Meeting Abstract

    Noy, A.; Thet, W. S.; Vemuri, S.; Seshan, V.; Batlevi, C. L.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Habermann, T. M.; Hamlin, P. A.; more...
    Blood (2024)

    Fulltext@MSK | Save